Office of Research & Development |
![]() ![]() |
Project Number: | I01CX001503-01A1 |
Title: | Beta Adrenergic Antagonist For The Healing of Chronic Diabetic Foot Ulcers |
Principal Investigator: | Sara Dahle |
Location: | Martinez, CA |
Congressional District Code: | 7 |
Research Service: | Clinical Science R&D |
Project Period: | April 2018 - March 2023 |
FY 2021 Funding Amount: | $173,913 |
Total Award Amount (all years): |
$708,813 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Intro: This study will investigate the safety and efficacy of using timolol, a non-selective beta adrenergic antagonist (BAA), topically to treat diabetic foot ulcers. We hypothesize that topical timolol is more effective in achieving wound closure than using the standard of care (SOC) treatment for diabetic foot ulcers, and is a safe therapeutic alternative. Research Design/Methods: The study is a Phase 2 randomized, double blinded, controlled and parallel-group clinical trial with 2 treatment... |